Status:

RECRUITING

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Sclerosis, Multiple

Neuromyelitis Optica Spectrum Disorder

Eligibility:

All Genders

Brief Summary

The influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective study of pregnancy and MS in 1998, counsel...

Detailed Description

METHODOLOGY Prospective, observational, multicentric and national epidemiological study, within the scope of the OFSEP, including all groups of patients eligible to participate in the Observatoire Fra...

Eligibility Criteria

Inclusion Criteria:

  • All groups of patients eligible to participate to the Observatoire Français de la Sclérose en Plaque (OFSEP), including :
  • Definite Multiple sclerosis (MS) according to McDonald criteria
  • Whatever the clinical course (single attack MS, relapsing-remitting MS, secondary progressive MS, primary progressive MS)
  • Radiologically Isolated Syndromes (RIS) (will be validated by the RIS expert group)
  • Clinically Isolated Syndromes (CIS)
  • Neuromyelitis optica (NMO) and NMO spectrum disorders (will be validated by the "Neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés" (NOMADMUS) expert group)
  • No age limit (patients under the age of 18 might be included, provided informed consent is obtained from the parents)
  • Ongoing pregnancy: there will be no limit in the gestational age at inclusion. Women can be included at any time before delivery, but the gestational age at inclusion will be recorded and introduced in the analyses whenever pertinent. However, neurologists and patients will be encouraged to start the study as soon as pregnancy is diagnosed.
  • Able to give informed consent
  • Able to read and/or understand French

Exclusion Criteria:

  • None

Key Trial Info

Start Date :

August 12 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 12 2036

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT03900221

Start Date

August 12 2019

End Date

August 12 2036

Last Update

January 5 2026

Active Locations (48)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (48 locations)

1

Chu D'Amiens

Amiens, France, 80054

2

Centre Hospitalier Annecy Genevois

Annecy, France, 74000

3

Centre Hospitalier d'Avignon

Avignon, France, 84000

4

Hopital Jean Minjoz

Besançon, France, 25030